SHUKRA PHARMACEUTICALS
|
The Current P/S Ratio of SHUKRA PHARMACEUTICALS is 12.76.
Share Price | ₹112.2 | Dec 24,2024 |
Market Cap | ₹491.4 Cr | |
Sales-TTM | ₹38.5 Cr | TTM-Standalone Results |
Price/Sales | 12.76x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SHUKRA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹491.4 Cr] as on Dec 24,2024
(/) Sales [ ₹38.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 12.76x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay '12.76 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SHUKRA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SHUKRA PHARMACEUTICALS
PS Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.36x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 4.79x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.31x.
How does SHUKRA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SHUKRA PHARMACEUTICALS | 38.5 | 12.76 | 491.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.67 | 436,103.0 |
CIPLA LTD | 26,512.0 | 4.50 | 119,196.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.75 | 112,752.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.52 | 97,041.2 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.82 | 153,540.0 |
MANKIND PHARMA LTD | 11,018.0 | 10.90 | 120,073.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 10.25 | 115,112.0 |
LUPIN LTD | 21,431.3 | 4.62 | 98,925.3 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.42 | 73,314.6 |
ABBOTT INDIA LTD | 6,066.1 | 9.97 | 60,480.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHUKRA PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.42x |
Max industry PS | 17.82x |
Median industry PS | 8.67x |
Average industry PS | 8.20x |
You may also like the below Video Courses